Treatment time cut for microwave prostate therapy:
This article was originally published in Clinica
Executive Summary
Urologix has begun a US clinical trial to assess the effect of reducing the treatment time of its non-surgical microwave heat ablation therapy for benign prostatic disease. Four patients have already been treated successfully with the Targis system after researchers more than halved the standard one-hour therapy, said the Minneapolis, Minnesota-based company. Positive results from the trial, which is being carried out under a supplemental investigational device exemption from the FDA, could lead to shorter treatment time without compromising patient comfort, complications or long-term clinical outcomes, according to Urologix.